Articles related to PATIENT SAFETY

“Real-world driving behavior appears to be a promising digital biomarker for detecting early cognitive impairment. These subtle, progressive changes in mobility and driving patterns may help clinicians identify emerging cognitive impairment earlier, guide decisions around driving safety, and support timely interventions to preserve independence and mobility in aging adults.” – Neurologist Mill Etienne, MD

“When I ask hospitals about who is leading their immediate-use compounding initiatives, sometimes I get a blank stare from the pharmacy department, and often an even more blank stare from nursing.”

A device that restricts blood flow and is worn around the neck, that has not been shown to provide any clinical benefit, is being sold to vulnerable populations—including children as young as 13.

Austrian medical authorities have emphasized that no non-credentialed individual—let alone a child—may be present or participate in any part of a surgical procedure, regardless of consent or supervision.

The FDA’s Class II designation indicates that exposure or usage of ‘a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.’

If your patients have the recalled deodorant, they should stop using it. Advise to throw it away or return it to the store.